Patient Guide: A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 90 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06269107
Status: COMPLETED
Condition: Type 2 Diabetes
Phase: PHASE3

Find a Study Location Near You

This study is available at 90 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • La Jolla, California
  • Lancaster, California
  • Palm Springs, California
  • • And 87 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily